CTI

Welcome to the Brand page for “CTI”, which is offered here for Synthesis of non-living compounds that affect cellular signaling pathways to the order and specification of others, for use in medical applications;laboratory research and developmental services in the field of non-living biochemical and therapeutic products that affect cellular signaling pathways;.

Its status is currently believed to be active. Its class is unavailable. “CTI” is believed to be currently owned by “CELL THERAPEUTICS, INC.”